Downloads provided by UsageCounts
Dataset of A Review on the Efficacy, and Safety of nab-paclitaxel with Gemcitabine in Combination with other Drugs as New Therapeutic Strategies in Pancreatic Cancer Table 1. Patient characteristics. Table 2. The Joanna Briggs Institute Critical Appraisal Checklist Table 3. The Joanna Briggs Institute critical appraisal checklist for quasi-experimental studies (non-randomized experimental studies) Table 4. Comparison of response to treatment Table 5. Summary of all grades Adverse Events (AE) in treatments that include placebo Table 6. Summary of all grades Adverse Events (AE) in treatments that include no placebo
Tarextumab, pancreatic cancer, Ibrutinib, Necuparanib, pancreatic ductal adenocarcinoma, PDAC, PRISMA, Review, Gemcitabine, nab-paclitaxel, Clinical trials, Systematic review, Enzalutamide, cancer, Apatorsen, Adverse Events, Cisplatin, Efficacy and safety, Momelotinib, Placebo
Tarextumab, pancreatic cancer, Ibrutinib, Necuparanib, pancreatic ductal adenocarcinoma, PDAC, PRISMA, Review, Gemcitabine, nab-paclitaxel, Clinical trials, Systematic review, Enzalutamide, cancer, Apatorsen, Adverse Events, Cisplatin, Efficacy and safety, Momelotinib, Placebo
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
| views | 5 | |
| downloads | 1 |

Views provided by UsageCounts
Downloads provided by UsageCounts